Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2025-12-24 @ 9:36 PM
NCT ID:
NCT03621332
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Diagnosis of advanced (not amenable to curative surgical resection) soft tissue sarcoma (histology confirmed by sarcoma histopathologist)
* Starting 1st line palliative chemotherapy or 3rd line palliative chemotherapy according to standard treatment guidelines.
* Able to communicate in English
* Mental capacity to provide informed consent and to participate in the study (as determined by the treating physician).
* Patients must be able to complete questionnaires themselves (a prerequisite for 'patient reported outcome' data).
* Patients must be under treatment or follow-up at one of the participating centres
Exclusion Criteria:
* Patients with GIST, Ewing sarcoma, rhabdomyosarcoma and desmoplastic small round cell tumour.
* Patients who have already started 1st line or 3rd chemotherapy.
* Patients who are too ill to receive any further systemic treatment (death is imminent), as determined by the referring health care professional
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03621332
Study Brief:
Protocol Section:
NCT03621332